TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml

7680006120037 CH-612 J07CA02 08.08.
TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
1 / 3
google

Details

Product number
0061201
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
toxoidum diphtheriae 20 U.I., toxoidum tetani 40 U.I., bordetellae pertussis antigenum: toxoidum pertussis 25 µg et haemagglutininum filamentosum 25 µg, virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.3 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg et kalium, ethanolum 2 mg, phenoxyethanolum, acidum aceticum glaciale q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: glutaralum, neomycinum, streptomycinum, polymyxinum B.

Articles (1)

Tetravac, suspension injectable
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
08/05/2024
Professional SmPC
Français
08/05/2024
Professional SmPC
Italien
08/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 UI Substance Wirkstoff (Principe actif)
(N/A)
40.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance WIIS
(N/A)
25.0 UG Substance WIIS
(N/A)
29.0 U Substance Wirkstoff (Principe actif)
(N/A)
7.0 U Substance Wirkstoff (Principe actif)
(N/A)
26.0 U Substance Wirkstoff (Principe actif)
(N/A)
0.3 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
12.5 UG Substance HBESI
(N/A)
- Substance HBESI
(N/A)
2.0 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK
(N/A)
- Substance HIMDK

Reimbursement information

Public price
CHF 38.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/04/2000

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
612
Drug name
Tetravac, suspension injectable
Galenic form
INJFS
ATC Code
J07CA02
Authorization status
Z
Dispensation category
B
First authorization
18/08/1999
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Diphtherie, Tetanus, Pertussis und Poliomyelitis, ab dem vollendeten 2. Lebensmonat bis zum vollendeten 7. Lebensjahr

Packaging details

Description (FR)
TETRAVAC susp inj av 1 aiguille ser pré 0.5 ml
Description (DE)
TETRAVAC Inj Susp mit 1 Nadel Fertspr 0.5 ml
Market launch
18/08/1999
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes